Previous 10 | Next 10 |
REDWOOD CITY, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced a strategic collaboration with Radius Health, Inc. (Radius, Nasdaq: RDUS) to pursue regulatory approval of the Guardant360 ® CDx as a companion diagnostic for elacestrant (R...
Radius Health inks licensing deal for elacestrant Radius Health Inc. ( RDUS ) announced that it has inked an exclusive global license agreement with privately-held Menarini for developing and commercializing of elacestrant. The drug candidate is currently being assessed in a Phase 3 study as...
WALTHAM, Mass., July 27, 2020 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq: RDUS) announced today that it will release its second quarter financial results on Monday, August 10, 2020. The Company will host a conference call and live audio webcast at 8:30 a.m. ET that day to discuss the results...
For development and commercialization of oral SERD elacestrant, a selective estrogen receptor degrader, The Menarini Group and Radius Health (NASDAQ: RDUS ) +10.2% AH entered into a exclusive global license agreement . More news on: Radius Health, Inc., Stocks on the mo...
Menarini licenses global development and commercialization rights of elacestrant, an oral SERD currently in late stage Phase 3 development Elacestrant further strengthens Menarini’s global oncology portfolio, recently bolstered by the acquisition of Stemline Therapeutics in the...
Radius partner Teijin Pharma has submitted a New Drug Application for abaloparatide-SC for treatment of osteoporosis in Japan WALTHAM, Mass., May 27, 2020 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS), t...
Radius Health, Inc. (RDUS) Q1 2020 Earnings Conference Call May 7, 2020 04:45 PM ET Company Participants Elhan Webb – Vice President, Investor Relations Jesper Hoeiland – President and Chief Executive Officer Kelly Martin – President and Chief Executive Offic...
Image source: The Motley Fool. Radius Health (NASDAQ: RDUS) Q1 2020 Earnings Call May 07, 2020 , 4:45 p.m. ET Operator Continue reading
The following slide deck was published by Radius Health, Inc. in conjunction with their 2020 Q1 earnings Read more ...
Radius Health (NASDAQ: RDUS ): Q1 Non-GAAP EPS of -$0.59 misses by $0.03 ; GAAP EPS of -$0.81 misses by $0.13 . More news on: Radius Health, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-19 10:10:00 ET July 19, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Biotech, Cleantech Sectors. The newest biotech companies are involved in blood disorder treat...
A look at the top 10 most actives in the United States Ocean Power Technologies Inc. (OPTT) rose 54.4% to $0.4264 on volume of 158,036,142 shares Versus Systems Inc. (VS) rose 73.5% to $2.29 on volume of 40,036,424 shares Tesla Inc. (TSLA) rose 5.3% to $220.97 on volume of 32,375,487 shar...
Ferrous, Nonferrous and Finished Steel Sales Volumes Up Sequentially Radius Board Declares Quarterly Dividend PORTLAND, Ore., July 02, 2024 (GLOBE NEWSWIRE) -- Radius Recycling, Inc. (NASDAQ: RDUS) today reported results for the third quarter of fiscal 2024 ended May 31, 2024. ...